BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ORIONPHARM

All Eps Dividend Board Agm Q1 Q2 Q3

ORIONPHARM 24-Jan-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 31, 2017 at 5:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.

ORIONPHARM 13-Nov-2016

The Board of Directors has recommended 15% cash dividend for 18 months period from Jan 01, 2015 to June 30, 2016. Date of AGM: 20.12.2016, Time: 10:30 AM, Venue: Officer's Club, 26 Baily Road, Dhaka, Record Date: 01.12.2016. The Company has also reported Consolidated EPS of Tk. 5.65, Consolidated NAV per share of Tk. 69.99 and Consolidated NOCFPS of Tk. 16.62 for 18 months period from Jan 01, 2015 to June 30, 2016.

ORIONPHARM 07-Nov-2016

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2016 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2016.

ORIONPHARM 02-Nov-2016

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2016 at 5:00 PM to consider, among others, audited financial statements of the Company for the 18 months period from January 01, 2015 to June 30, 2016.

ORIONPHARM 10-May-2016

The Company has informed that the Board of Directors of the Company has decided, according to the Companies Act, 1994 and the BSEC Directive Dated April 27, 2016, to extend the Financial Year 2015 of the Company by an additional period of 6 months comprising to 18 months period ending on 30th June, 2016 instead of 31st December, 2015 in order to comply with the uniform income year from July to June as per provision of Section 9 of the Finance Act, 2015.

ORIONPHARM 25-Oct-2015

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 29, 2015 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on September 30, 2015.

ORIONPHARM 13-May-2015

The Board of Directors has recommended 15% cash dividend for the year ended on December 31, 2014. Date of AGM: 28.06.2015, Time: 10:30 AM, Venue: Orion Pharma Plant, Shumilpara, Siddirgonj (South Adjacent of Adamjee EPZ), Narayongonj. Record Date: 21.05.2015. The Company has also reported consolidated EPS of Tk. 4.25, consolidated NAV per share of Tk. 67.50 and consolidated NOCFPS of Tk. 13.98 for the year ended on December 31, 2014.

ORIONPHARM 06-May-2015

As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on May 12, 2015 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2014.

ORIONPHARM 11-May-2014

The Board of Directors has recommended 15% cash dividend for the year ended on December 31, 2013. Date of AGM: 22.06.2014, Time: 10:30 AM, Venue: Orion Pharma Plant, Shumilpara, Siddirgonj (South Adjacent of Adamjee EPZ), Narayongonj. Record Date: 21.05.2014. The Company has also reported consolidated EPS of Tk. 4.06, consolidated NAV per share of Tk. 65.23 and consolidated NOCFPS of Tk. 10.74 for the year ended on December 31, 2013.

ORIONPHARM 06-May-2014

As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on May 10, 2014 at 5:00 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2013.

Previous Next page